Trial Profile
An observer-blind, randomized, parallel-group study to compare the efficacy of two rizatriptan prescribing portions for the treatment of migraine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Rizatriptan (Primary)
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- 01 Dec 2009 Results published in Headache.
- 29 Sep 2009 Actual patient number changed from 202 to 197 as reported by ClinicalTrials.gov.
- 12 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.